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Abstract: Tissue engineering is a new technique to help dam-
aged cartilage treatment using cells and scaffolds. In this study
we tried to evaluate electrospun scaffolds composed of gelatin/
glycosaminoglycan (G/GAG) blend nanofibers in chondrogenesis
of bone marrow-derived mesenchymal stem cells (BMMSCs).
Scaffolds were fabricated by electrospinning technique with dif-
ferent concentration of glycosaminoglycan (0%, 5%, 10%, and
15%) in gelatin matrix. BMMSCs were cultured on the scaffolds
for chondrogenesis process. MTT assay was done for scaffold’s
biocompatibility and cells viability evaluation. Alcian blue stain-
ing was carried out to determine the release of GAG and reverse
transcription polymerase chain reaction (RT-PCR) was done for
expression of COL2A1 and also immunocytochemistry assay
were used to confirm expression of type II collagen. Scaffold
with 15% GAG showed better result for biocompatibility
(p =0.02). Scanning electron microscopy (SEM) micrographs
showed that MSCs have good attachment to the scaffolds. Alcian
blue staining result confirmed that cells produce GAG during dif-
ferentiation time different from GAG in the scaffolds. Also the
results for RT-PCR showed the expression of COL2A1 marker.
Immunocytochemistry assay for type II collagen confirm that this
protein expressed. Scaffold comprising 15% GAG is better
results for chondrogenesis and it can be a good applicant for car-
tilage tissue engineering. © 2018 Wiley Periodicals, Inc. J Biomed
Mater Res Part A: 00A: 000–000, 2018.
Key Words: Tissue engineering, cartilage, mesenchymal stem
cells, electrospun, glycosaminoglycan
How to cite this article: Honarpardaz A, Irani S, Pezeshki-Modaress M, Zandi M, Sadeghi A. 2018. Enhanced chondrogenic differ-
entiation of bone marrow mesenchymal stem cells on gelatin/glycosaminoglycan electrospun nanofibers with different amount of
glycosaminoglycan. J Biomed Mater Res Part A. 2018:00:1–11.
INTRODUCTION
Cartilage is avascular and aneural tissue that covers and pro-
tects the end of bones and provides bones movement with
less tenses. Cartilage tissue has low chondrocyte population
and also because does not contain blood vessels to transfer
nutrient to the cells it lacks the ability to self-repair.1,2 Carti-
lage is a tissue with rich collagen and proteoglycan and in
the mature tissue collagen type II with proteoglycans which
provide mechanical strength to tolerate impact and load.3
However, trauma and disease, damage the cartilage and
make it dysfunction. Damaged cartilage retain to degraded
until pain and impaired mobility outcome, and without any
treatment a joint replacement is necessitated.4 Prevalent
clinical treatment utilizes for treating the damaged cartilage
such as microfracture, abrasion arthroplasty, mosaicplasty,
and autologous chondrocytes implantation which has no
complete adequate restoration result yet.5,6
Over the previous decade tissue engineering including
biocompatible and biodegradable biopolymers combination
with stem cells proposed in order to repair or regenerate
the injured tissues.7–9 There are three main parts in tissue
engineering: scaffold, cell, and growth factor.
Mesenchymal stem cells (MSCs) are unique population of
adult multipotent progenitor cells existed in the bone marrow
(BM), which are capable of differentiating to the adipocytes,
osteoblasts, chondrocytes, and vascular smooth muscle.10,11
MSCs derived from BM as a source of cells in cartilage tissue
engineering studies12 because of its differentiation potential,
improve angiogenesis, and prevent apoptosis. Different source
of stem cells could be used for tissue engineering such as adi-
pose derived stem cell,13 BM derived stem cell14 and syno-
vium derived stem cells.15 BM derived stem cells have proven
to be the best stem cells for cartilage tissue regeneration
based on the cell surface CD markers.16,17
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One of the main objectives in cartilage tissue engineering is to
fabricate the scaffolds that mimic the natural cartilage extracellu-
lar matrix (ECM) and provides three-dimensional (3D) structure
for cell adhesion and proliferation.18 Researchers tried to use dif-
ferent natural and synthetic biomaterials to fabricate scaffolds
that mimic cartilage ECM structure,19,20 or just synthetized mate-
rial could be used.21 Utilizing the natural materials in scaffold
preparation could reduce inflammatory concerns and also benefit
naturally degradation by body.22
Gelatin (G) is a natural biotic material with highest simi-
larity to collagen, which has cell compatibility, low toxicity
and has no inflammation.23 Gelatin is used as one of the
favorable biomaterials in cartilage tissue engineering.24–26
Glycosaminoglycans (GAGs) such as chondroitin sulfate
(CS) which are existing in native cartilage tissue have capacity
to provide chondrogenesis cell signaling.27,28 CS is utilized
with many other biomaterials to fabricate scaffolds for carti-
lage tissue regeneration.29 Therefore, blend of gelatin and CS
is a proper applicant for cartilage tissue engineering. During
last decade composition of gelatin and CS was utilized with
other materials for cartilage tissue engineering.30,31
Electrospinning is a well-organized technique to fabricate
nanofiberous scaffolds with interconnected pores.32 Nanofiber-
ous electrospun scaffolds have shown more suitability for carti-
lage tissue engineering.33 Because of advantages in fast, cost
efficiency, easy fabrication as well as enhancing cell functions via
fiber surface properties, electrospinning becamepopular for carti-
lage tissue engineering.34 Combination of gelatin and GAG were
also used to manufacture electrospun scaffold as biocompatible
and biodegradable substrate for cell culture,35 but to the best of
our knowledge no studies on G/GAG electrospun nanofiberous
scaffold in cartilage tissue engineering applications have been
reported.
Growth factors are important to guide cells to differenti-
ate into special tissue but there are concerns about use of
growth factors because they have short half-lives and high
cost.36 Therefore, in this study we aimed to explore and eval-
uate the electrospun gelatin based nanofibers containing dif-
ferent ratio of GAG to enhance differentiation of MSCs to
chondrocytes without any growth factor.
EXPERIMENTAL
Materials
Gelatin (bovine skin; Sigma Aldrich, type B, Darmstadt, Ger-
many) and CS (type A) were used. Electrospinning solutions
were prepared as previously reported.35 Briefly gelatin was
dissolved in trifluoroethanol (TFE) (Sigma Aldrich) and GAG
was dissolved in water. The TFE/water with ratio of 50/50
was used as co-solvent system for dissolving gelatin and GAG
at room temperature. Then three different concentration of
mixed G/GAG (100: 0, 95:5, 90:10, and 85:15) with total poly-
mer ratio of 13% (w/v) were prepared and homogenized at
room temperature for overnight. Then solution has taken in a
syringe for prior electrospinning (Co881007 NYI, ANSTCO,
Tehran, Iran) process. For cell adhesion and proliferation, the
following culture media was acquired and prepared from
Gibco, Germany: Dulbecco’s Modified Eagle’s Medium (DMEM),
phosphate buffered saline (PBS) and trypsin. Ascorbic acid and
dexamethasone (Sigma Aldrich) were used as differentiation
media.
Fabrication of gelatin/glycosaminoglycans nanofibers
Gelatin was dissolved in TFE and GAG was dissolved in water.
Then three different concentration ratio of mixed gelatin/GAG
(G0: 100:0, G1: 95:5, G2: 90:10, and G3: 85:15) solutions with
total polymer concentration of 13% (w/v) were prepared and
homogenized at room temperature for overnight. Then solu-
tion has taken into a 5 ml syringe prior electrospinning
(Co881007 NYI; ANSTCO, Tehran, Iran) process, then horizon-
tal system electrospinning was done by following optimized
parameters: applied voltage; 19 kV, feeding rate; 0.6 ml/h,
distance between collector and nozzle; 120 mm. Nanofibers
were collected by cylindrical collector covered by aluminum
foil for 60 min. The nanofiberousrs were chemically cross-
linked using glutaraldehyde (GA) vapor 20% (wt/vol) for 4 h
at 25C, followed by immersion in 1% GA solution for 1 h.35
The nanofiberousrs were chemically cross-linked using GA
vapor 20% (wt/vol) for 4 h at 25C, followed by immersion
in 1% GA solution for 1 h.
Physical and chemical characteristics
Scanning electron microscopy. Scanning electron micros-
copy (SEM; VEGA, TESCAN, and Czech) was done after gold
sputter coating to verify G/GAG nanofibers morphology and
sizes. For measuring nanofibers diameter, at least 100 differ-
ent fibers from each scaffold were measured and then analy-
sis was carried out by image analysis software (ImageJ
1.42q; National Institute of Health, Bethesda, Maryland).
Contact angle. Surface hydrophilicity of G/GAG electrospun
nanofibers was measured by calculating static contact angle
(G10 KRUSS; XXX, Hamburg, Germany). Scaffolds were cut in
to 5 × 5 mm and then 2 μl of deionized water was dropped
on the solid surface of the scaffolds. Data were captured by
charge-coupled device camera and analyzed with software.
All data are the mean value of five repetitions.
Fourier transform infrared spectroscopy analysis. The
chemical structure of the nanofibers were analyzed using
Fourier transform infrared spectroscopy (FTIR) using a FT-
IR spectrophotometer (EQUINOX 55; BRUKER, Berlin, Ger-
many). The infrared spectra of the samples were measured
over a wavelength range of 4000–400 cm-1.37
Sterilization of scaffolds
Sterilization of the scaffolds was done in three stages and
each stage done triplicate. In stage one 70% ethanol was uti-
lized to sterilize scaffolds. In second stage sterile water was
used to remove ethanol from the scaffolds. At last stage ster-
ile PBS was used to remove remained ethanol from scaffolds.
Cytocompatibility and viability study
Human bone marrow-derived MSCs (hBM-MSCs) were
acquired from Boneyakhteh Institute of Iran. Cells were cul-
tured in DMEM culture media (Gibco, Darmstadt, Germany)
with 10% FBS (Gibco) and sustained at 37C in 5% CO2
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humidified incubator. The time that cells confluency reached
to the optimum amount, cells were washed by PBS (pH 7.4)
and undetached by using trypsin/ethylenediaminetraacetic
acid. Cytocompatibility of G/GAG nanofibers were checked
by seeding hBM-MSCs onto the scaffolds.
For viability test 3-(4, 5-dimethylthiazol2-yl)-2,
5-diphenyltetrazolium bromide (MTT) powder (Sigma Aldrich)
was used. MSCs were seeded in 96-well microplate at a den-
sity of 104 cell/well for 24, 48 and 72 h. For MTT assay
then samples (different percentage of GAG: 5, 10 and 15%)
were incubated for 4 h with MTT solution and then
dimethyl sulfoxide (Sigma Aldrich) added to samples.
Absorbance of solution was measured by Elisa reader
(BioTek EL × 800) at wavelengths of 490/630 nm. All tests
were done in triplicates.
Cell adhesion study
For cell attachment test, human mesenchymal stem cells
(hMSCs) were seeded in 96-well microplate on
5 × 5 mm G/GAG scaffolds with a density of 1 × 104 cell/
well. Then after 1, 2, and 6 h MTT assay was used to deter-
mine amount of cells that attached to the scaffolds. First
scaffolds were washed by PBS three-times and placed on the
new wells. During the test, the samples were incubated for
4 h with MTT solution and then dimethyl sulfoxide (Sigma
Aldrich) was added to the samples. Absorbance of the solu-
tion was measured by Elisa reader (BioTek EL × 800) at
wavelengths of 490/630 nm. All tests were done in tripli-
cates. Also the cells present on the scaffolds proved by using
SEM. At first step samples were coated by thin layer of gold
and then SEM (VEGA, TESCAN, and Czech) was used to study
the cells behavior.
4, 6-diamidino 2-phenylindole staining
4, 6-diamidino 2-phenylindole (DAPI) staining was used to
show that the cells nuclear were healthy during differentia-
tion tests. Scaffolds were cut to 5 × 5 mm sections and
hMSCs were seeded on the scaffolds by density of 1 × 104
cell/well as sample test and also on the tissue culture plate
(TCP) as control. After 24 h incubation, samples were
washed with PBS (pH 7.4) and then 4% paraformaldehyde
was added to them and after 10 min washed with PBS again.
For making cells penetrable we used 0.1% triton X-100 and
after 2 min washed with PBS. Then DAPI stain (Sigma
Aldrich) was used to stain the cells’ nuclei for 5 min in the
dark. After that samples were washed by PBS for three-times
and then cells photography by Nikon fluorescent microscope
(Eclips Terminal Emulator 2000-S, Japan).
Chondrogenic differentiation of human mesenchymal
stem cells
For chondrogenesis differentiation, hMSCs were seeded on
G/GAG scaffold by density of 1 × 104 cell/well (96 well
microplate) and also cells with the same density seeded on
TCP as a control, in presence of chondrogenesis differentia-
tion medium for 3 weeks. Cells were cultured in growth
medium (DMEM with 10% FBS) for 24 h. After that medium
was changed with differentiation medium includes:
dexamethasone (1 × 10−7 μM), acid ascorbic (0.1 M), and
insulin transferrin selenium (ITS 1%), all prepared from
Sigma Aldrich, Germany. During the test differentiation
medium was refreshed two-times a week for 3 weeks. At
certain days MTT assay was used to show viability of differ-
entiated cells during test, culture media was removed from
the wells and MTT medium include DMEM and 10% FBS
was added and incubated for 4 h. Then dimethyl sulfoxide
was used to dissolve dregs. Eliza reader (BioTek EL × 800)
was used to measure color absorbance of solution at wave-
length of 490/630 nm. Viability of differentiated cells was
checked by DAPI staining as previously described, and SEM
used to inspect morphology and attachment. For SEM, hMSCs
were seeded on G/GAG nanofiber at density of 1 × 104 cell/
well in 96-well plate. After 72 h. Scaffolds were washed with
PBS three-times and 4.5% glutaraldehyde was used for 2 h
to fix cells on scaffolds. PBS was used to wash scaffolds and
graded ethanol series (60–100%) were used to dehydrate
the scaffolds and replace water. Then scaffolds were dried
overnight and sputter coated by gold prior examination by
SEM (SEM, VEGA, TESCAN, Czech).
Alcian blue staining
Differentiated cells’ expressed GAGs were determined by
Alcian blue staining. HMSCs were seeded on 5 × 5 mm G/GAG
scaffold by density of 1 × 104 cell/well (96-well microplate)
with differentiation media. Tissue culture plate (TCP) with
differentiation media and cell seeded on the scaffolds with-
out differentiation media were used as control. Also G/GAG
scaffold stained with Alcian blue to insure that GAGs
expressed by differentiated cells have taken stain.38
For preparing Alcian blue 3 ml of acetic acid was added
into 97 ml of distilled water then 1 mg of Alcian blue 8GX
was added to prepared 3% glacial acetic acid and adjust pH
to 2.5, using acetic acid. The solution filtered and a crystal of
thymol was added.
After 1 and 3 week of differentiation test, the scaffolds
were fixed by 1% glutaraldehyde for 20 min at room tem-
perature. Then the samples washed three-times with PBS.
Scaffolds kept for 30 min in prepared Alcian blue stain, after
that scaffolds were washed by hydrochloridric acid (0.1
Mol). Scaffolds then washed by PBS for three-times to
remove hydrochloridric acid, and at the end stained scaffolds
examined under invert microscope (BEL).
Reverse transcription polymerase chain reaction
Chondrogenesis differentiation was investigated by expression
of COL II with RT-PCR. The hMSCs were cultured on
1 × 1 cm G/GAG scaffolds in 6-well plate at a density of
1 × 106 cells/well with differentiation media for 2 weeks.
Also another set of the prepared scaffolds cultured with the
same amount of cell with normal media was used as control.
Total RNA was extracted by using RNA extraction kit (Arya
Tous, Tehran Iran) as maintained by protocol. Reverse tran-
scriptase enzyme was utilized to convert extracted RNA to
c-DNA. The RT-PCR reaction mixture contained 5.5 λ cDNA,
0.5 λ forward primer, 0.5 λ reverse primer, 12.5 λ master mix
and 6.5 λ distilled water. Reactions had done with initial
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activation at 95C for 10 min, then followed by 35 cycles of
denaturation at 94C for 30 s and anneal at 58C for 30 s,
and at 72C for 30 s for elongation. Gene activity could be
shown by determine m-RNA value in cell that means gene
expression in the cells. RT-PCR has two phases: produce c-
DNA from extracted RNA, and then prepared c-DNA utilized
for PCR. For RT-PCR all data were gathered from GenBank
(NCBI) and then primer designed by Oligo 7 and Gene Runner
software and blasted with Primer Blast (NCBI) software.
Designed primers were ordered and purchased from Taka-
pouzis: COL II, F: 5’-GGAGAACCTAGAGACAACAAGA-30, R:
50- CATCCGGGCAGCACACTTTC-30, and GAPDH cDNA was
utilized as a control, F: 50- CTGGCCAAGGTCATCCATG-30, R:
50- GCCATCACGCCACAGTTTC-30.
Immunocytochemistry
For detecting collagen II (COLII) protein immunocytochemistry
was used. Density of 1 × 104 cells/well seeded on
5 × 5 mm G/GAG scaffolds in the 4-well plate, also cells cul-
tured in TCP as control. Differentiation media was refreshed
twice a week. After 3 weeks differentiated cells were washed
with PBS and then fixed with 4% paraformaldehyde for
20 min at 4C, wells were washed with PBS for 5 min over
again. Goat serum was utilized as blocking serum, for 45 min
at room temperature, then 4% Triton used for 5 min. Goat
FIGURE 1. SEM micrograph of electrospun G/GAG nanofiber scaffold. Scale bar: 5 μm. (A) gelatin, (B) gelatin/GAG 95/5, (C) gelatin/GAG
90/10,(D) gelatin/GAG 85/15






56.81 189 10 G0
34.78 191 10 G1
29.99 210 10 G2
27.45 230 10 G3
TABLE II. Contact Angle Property of Gelatin/GAG Scaffolds
Contact angle Scaffold
34.1o  0.5 o G0
32.9o  0.5 o G1
28.7o  0.5 o G2
25.3o  0.5 o G3
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serum was removed and cells incubated with anti-mouse colla-
gen types II antibody overnight at 4C. Wells washed with PBS
and secondary conjugated antibody was added and incubated
for 1 h. at 37C. Thereafter, wells washed with PBS-Tween and
then DAPI stain was utilized for 5 min, and finally washed by
PBS and examined by fluorescent microscope.
FIGURE 2. The FTIR analysis of cross-linked gelatin/GAG electrospun scaffolds containing different ratio of GAG: (a) GAG 0 (b) GAG 5 (c) GAG
10 (d) GAG 15.
FIGURE 3. SEM images of cross-linked gelatin/GAG electrospun scaffolds containing different ratio of GAG: (A) gelatin, (B) gelatin/GAG 95/5,
(C) gelatin/GAG 90/10, (D) gelatin/GAG 85/15.
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Statistical analysis
For statistical analysis all data gathered from tests, statistical
software SPSS V.23 was used and one-way ANOVA, difference
of p < 0.05 was considered to be statistically significant.
RESULTS
Morphology and properties of random electrospun
gelatin/glycosaminoglycan nanofibers
Morphology of the G/GAG nanofibers was shown in Figure 1.
All scaffolds, reveal bead-free nanofiberous structure fabricated
successfully. The mean fiber diameter after cross linking was
listed in Table I and the results demonstrated that increasing
the amount of GAG lead to decreasing the mean fiber diameter.
Hydrophilicity
Evaluation of hydrophilicity of the scaffolds was achieved by
measuring the contact angle as presented in Table II. The
obtained results (G0: 34.16o, G1: 32.98o, G2: 28.72o, G3:
25.34o) in gelatin scaffold (34.16o) was higher than the G3
sample (25.34o). The mean values for hydrophilicity were
increased with increasing the GAG ratio in the scaffold
matrix.
Fourier transform infrared spectroscopyThe characteri-
zation of the chemical structure of the cross-linked electro-
spun scaffolds, was carried out using FTIR spectroscopy.
Representative spectra for cross-linked G/GAG electrospun
scaffolds containing different ratio of GAG in the wavenum-
ber range of 400–4000 cm−1 cm−1are shown in Figure 1. The
cross-linked electrospun gelatin (GAG 0) spectrum displayed
several characteristic absorption bands at 3312 cm−1 for
NH2 and OH stretching vibration, 3100–2900 cm
−1
for C H aliphatic group stretching vibration (3072 cm−1 for
alkenyl C H stretch and 2934 cm−1 for CH2 asymmetrical
stretching), 1651 cm−1 for amid 1 (C O) stretching vibra-
tion, 1541 cm−1 for amid 2 (N H) bending vibration,
1451 cm−1 for CH2 bending, 1278 cm
−1 for amid 3 (C N)
stretching vibration and 1240 cm−1 for -C N stretching.39,40
FIGURE 4. Viability results of hMSCs cells for 24 and 72 h by MTT
assay. G3 (p = 0.02) (n = 3), ANOVA, **p < 0.05.
FIGURE 5. Optical microscopy images of cytocompability of scaffolds and TCP control group at 24 and 72 h. (A) G2, (B) G3. The dark areas that were
shown by arrows are scaffolds.
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Figure 2(B–D) displays the FTIR spectra of the cross-linked
G/GAG nanofibrous scaffolds. According to the previous
study, raw GAG sample showed characteristic peaks at
1031 cm−1 for C O C stretching vibration attributed to the
saccharide structure, 1274 cm−1 attributed to the negatively
charged SO4
2− groups of GAG molecules, 875 and 921 cm−1
for C O S vibration.5 Considering the presence of sulfated
groups in GAG chemical structure and their absence in cross-
linked gelatin chemical structure, the sulfide bands could be
taken to prove the presence of GAG in the cross-linked G/GAG
samples. The representative peak of GAG was observed at
1274 cm−1 for S O stretching vibration but as there is a peak
at 1278 cm−1 for amid 3 in cross-linked gelatin structure,
there is no significant difference in spectra (b), (c), and (d).
The peak at 1031 cm−1 for C O C stretching vibration is
attributed to the saccharide structure in GAG spectra. Increas-
ing the GAG content in samples leads to increasing this sac-
charide band in comparison of peak at 1079. Comparison the
spectra of cross-linked gelatin (GAG 0) and G/GAG blends
show that the intensity of peaks at 921 and 875 cm − 1 (for
C O S vibration), which is absent in gelatin, increases by
presence of GAG in electrospun scaffolds. These findings con-
firm the presence of varying levels of GAG in the gelatin/GAG
electrospun scaffolds. Figure 3 presents the images of cross-
linked G/GAG nanofibrous scaffolds.
Cytocompatibility and viability study
To evaluate that scaffolds were viable for cells, MTT assay
was done triplicate for each scaffold by using hMSCs for
72 h. Figure 4 shows the result of MTT assay that evaluate
the cell viability on scaffolds. G1 scaffold showed better
result (p = 0.01). Also Figure 5 shows that the cells are alive
and have tendency to the scaffold.
Cell adhesion
MTT test was done for evaluation hMSCs that attached to
the scaffolds after 1, 2, and 6 h. Results in Figure 6 shows
that all scaffolds have better adhesion than control and also
FIGURE 6. MTT assay results for cell attachment during 6 h, G3 showed
best attachment compare to other scaffolds and control (p = 0.02).
(n = 3), ANOVA, **p < 0.05.
FIGURE 7. SEM micrographs of hMSCs cultured on gelatin/Glycosaminoglycan for 24 h. (A) gelatin, (B) gelatin/GAG 95/5, (C) gelatin/GAG 90/10,
(D) gelatin/GAG 85/15, Scale bar 20 μm
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G3 scaffold has the best cell attachment (p = 0.02). Figure 7
shows SEM images that confirmed MTT results.
Chondrogenic differentiation confirmation
Alcian blue staining. Alcian blue staining was used to deter-
mined amount of GAGs that produced by differentiated cells
during 3 weeks. Based on pH = 2.5, Alcian blue just stain the
GAGs that cells produce, GAGs that used in scaffolds was not
take any stain in this pH. Figure 8 shows the results for Alcian
blue staining during 3 weeks. All scaffolds with cell under chon-
drogenic media were colored blue that means cells produced
GAGs, but controls with cell and also scaffolds without cells got
no color. G3 scaffolds have got more color to other scaffolds.
Also changes in morphology of the cells were checked by invert
microscope during test that confirmed the change in cells mor-
phology.38 Figure 9 shows the result of MTT test that prove cells
proliferation during the differentiation tests.
Reverse transcription polymerase chain reaction.
Figure 10 shows expression level of chondrogenic specific gene
Col II determined after 2 weeks of hMSCs culture under chon-
drogenic media. Results showed that expression of Col II was
increased during 2 weeks after cell culture under chondrogenic
media compare to control. G3 scaffold showed higher color that
means more expression of Col II gene compare to G2 scaffold.
Immunocytochemistry. This test was utilized to confirm
expression of collagen type II protein that is specific protein
during chondrogenesis, for 3 weeks. Our results show that
FIGURE 8. Alcian blue staining: (A) scaffold with no cell, (B) G2 scaffold with cell after 1 week, (C) G3 scaffold with cell after 1 week, (D) control scaf-
fold with no GAG after 1 week, (E) G2 scaffold with cell after 3 weeks, (F) G3 scaffold with cell after 3 weeks, (G) control scaffold with no GAG after
3 weeks.
FIGURE 9. Viability of differentiated cells for 3 weeks by MTT assay
(n = 3), ANOVA,**p < 0.05.
FIGURE 10. RT-PCR results for 2 weeks of cell differentiation test,
(A) G2 scaffold, (B) G3 scaffold.
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collagen type II protein expressed after 3 weeks of hMSCs
culture on G3 scaffold that showed as figure 11.
DISCUSSION
Fabrication of nanofibers depends on the final application of
the scaffolds. 3D scaffold should support cell proliferation in
the case of damaged tissue replacement. Designed nanofiber
should have ability to mimic the natural environment for cell
such as cell migration, metabolite transfer, biodegradable, and
so forth. The electrospinning technique provides the ways
that help to fabricate nanofibers that can mimic the natural
ECM structure. Electrospun nanofibers have potential ability
to support the cells proliferation and differentiation based on
their high porosity and nanofibers diameter. In this study
combination of gelatin and CS was used to prepare the scaf-
folds. The highest concentration for prepare the nanofibers
preparation was 15% based on previous study .35 In this
study different ratio of GAG was used to determine effect of
GAG on cell differentiation in chondrogenesis process. Gelatin
and GAG are both water-soluble. Therefore, the nanofibrous
scaffolds were cross-linked using both glutaraldehyde
vapor and solution. As shown in Figure 3, it can be
observed that with increasing GAG ratio in gelatin/GAG
nanofibrous scaffolds, increase in fiber fusing was observed,
which related to the lower crosslink density with glutaral-
dehyde in the scaffolds with higher GAG ratio due to the
presence of SO4
2− groups.41
MSCs were reported as a good source of cells for repairing
of cytoskeletal disorder because of their self-renewal and repair
ability.42 The source of MSCs is the one of concerns for
researchers, therefore many scientist try to find the best source
of MSCs for specific applications. Cell surface markers play
important role in cell differentiation. Many cell surface marker
of BM hMSCs are the same as chondrocytes such as CD44.43
Also CD105 and CD90 are the common markers on MSCs sur-
face that can find on chondrocyte.44 CD105 has a great role in
COL2A1 and ACAN expression.45 In this study hMSCs from BM
was utilized and results show that MSCs extracted from BM
have good ability to differentiate into chondrocyte.
Chondrocyte ECM in natural cartilage plays a main role
in attachment. For mimic the natural ECM in tissue engineer-
ing gelatin is a good choice because it has good
performances in many conditions. Gelatin can increase cell
attachment.46 Also gelatin is biocompatible, nontoxic, natural
based material with good biodegradation rate. Gelatin plays
its role in signal transferring for arginine-glycine-acid aspar-
tic sequence that controls the attachment, proliferation, and
differentiation of chondrocyte.47 In this study by adding the
GAG to gelatin in scaffold composition we try to increase the
attachment and proliferation. GAG in combination with gela-
tin in nanofiberous structure and highly porosity can have a
great impact on attachment potential of the scaffolds.48 SEM
images approve that G/GAG nanofiber structure is deferent
from gelatin nanofibers. Also MTT results shows increasing
attachment in scaffolds with high amount of GAG.
Several studies have shown that growth factors such as
TGF-β have effect on chondrogenesis which are expensive.49
Using the scaffold containing specific material can help
researchers to omit growth factors.50 GAGs are polysaccha-
rides that are the major component of cartilage. CS chains
bond to serine hydroxyl residue in specific proteins. CS with
its negative charge connects to the extra cell matrix that con-
trols many functional pathways in cells, one of these func-
tions is inhibition of inducing translocation of NF-κB by
reducing IL-1β in chondrocytes.51 CS can be work as signal
transporter that induces cell potential to differentiate to
chondrocyte.52 Also results show that CS could change poly-
L-lysine structure by changing electric charge and increasing
the negative charge. It could lead stem cell differentiate to
chondrocyte.53 Results show that increase in amount of CS
in scaffold could increase chondrogenesis of hMSCs.
This study shows that electrospun G/GAG nanofibers
with 15% GAG ratio can support cell proliferation and chon-
drogenesis of hBMSCs during 3 weeks culture without using
any growth factor. We suggest that these nanofibers have
great potential to use for cartilage tissue engineering.
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